Pediapharm Announces Q2 Results - Record Adjusted EBITDA, Record Revenue and 13th Consecutive Year-Over-Year Quarterly Revenue Growth
Stock Information for Medexus Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.